Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-274
Closed -$7.56K – 2729
2026
Q2
$7.56K Hold
274
– – ﹤0.01% 1934
2026
Q1
$4.01K Buy
274
+69
+34% +$1.01K ﹤0.01% 2025
2025
Q4
$2.59K Buy
205
+114
+125% +$1.68K ﹤0.01% 2107
2025
Q3
$1.4K Buy
91
+11
+14% +$177 ﹤0.01% 2236
2025
Q2
$1.26K Buy
+80
New +$1.21K ﹤0.01% 2211
2024
Q4
– Sell
-640
Closed -$16.7K – 2887
2024
Q3
$16.7K Buy
640
+446
+230% +$12.6K ﹤0.01% 2016
2024
Q2
$4.24K Buy
+194
New +$4.04K ﹤0.01% 2253
2024
Q1
– Sell
-56
Closed -$1K – 2632
2023
Q4
$1K Buy
56
+39
+229% +$785 ﹤0.01% 2401
2023
Q3
$0 Sell
17
-3
-15% -$59 ﹤0.01% 2256
2023
Q2
$0 Sell
20
-54
-73% -$1.09K ﹤0.01% 2452
2023
Q1
$1K Buy
+74
New +$1.42K ﹤0.01% 2203

Other funds holding RXO

Blue Trust's RXO Position: Q3 2026 in Review

Blue Trust sold out of RXO (RXO) in Q3 2026, closing a stake of 274 shares — an estimated $7.56K sold.

Blue Trust first reported a position in RXO in Q1 2023 and held it in 11 quarters. The position peaked at $16.7K in Q3 2024. 244 funds tracked by Wall St. Rank hold RXO as of Q3 2026.

  • Blue Trust reported no remaining RXO position as of Q3 2026 after selling out during the quarter.
  • Blue Trust sold 274 RXO shares in Q3 2026, an estimated $7.56K.
  • Blue Trust first reported a position in RXO in Q1 2023 and held it in 11 quarters.
  • Blue Trust's RXO position peaked at $16.7K in Q3 2024.
  • 244 funds tracked by Wall St. Rank held RXO as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.